WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics (TM), today announced that Alan Musso, Vice President and Chief Financial Officer, is scheduled to present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference at The New York Palace Hotel, on Thursday, June 12, 2008 at 2:30 p.m. Eastern Daylight Time.
